The Defined Daily Dose as a Tool in Pharmacoeconomics
作者： Karen W. Clarke , David Gray
DOI: 10.2165/00019053-199507040-00002
关键词:
摘要:
springer.com
sci-hub.se 参考文章(9)
Laure Papoz, EURODIAB, Utilization of Drug Sales Data for the Epidemiology of Chronic Diseases: The Example of Diabetes Epidemiology. ,vol. 4, pp. 421- 427 ,(1993) , 10.1097/00001648-199309000-00007
Lynn M. Jolicoeur, Amy J. Jones-Grizzle, J. Gregory Boyer, Guidelines for performing a pharmacoeconomic analysis American Journal of Health-system Pharmacy. ,vol. 49, pp. 1741- 1747 ,(1992) , 10.1093/AJHP/49.7.1741
T.J. Szuba, B. Westerholm, Studies on drug utilization: Bilateral case study in Poland and Sweden Social Science & Medicine. ,vol. 29, pp. 1363- 1366 ,(1989) , 10.1016/0277-9536(89)90236-0
M Maxwell, D Heaney, J G Howie, S Noble, General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. BMJ. ,vol. 307, pp. 1190- 1194 ,(1993) , 10.1136/BMJ.307.6913.1190
George A. Diamond, Timothy A. Denton, Jack M. Matloff, Free-for benefit: A stragety to improve the quality of health care and control costs through reimbursement incentives Journal of the American College of Cardiology. ,vol. 22, pp. 343- 352 ,(1993) , 10.1016/0735-1097(93)90036-Z
D.R Illingworth, D.W Erkelens, U Keller, G.R Thompson, M.J Tikkanen, Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin. The Lancet. ,vol. 343, pp. 1554- 1555 ,(1994) , 10.1016/S0140-6736(94)92945-9
G. BOËTHIUS, Approaches to assessing the rationality of drug usage in a developed country. Acta Medica Scandinavica. ,vol. 222, pp. 21- 26 ,(2009) , 10.1111/J.0954-6820.1987.TB05373.X
Michael Drummond, Arno Brandt, Bryan Luce, Joan Rovira, Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential. International Journal of Technology Assessment in Health Care. ,vol. 9, pp. 26- 36 ,(1993) , 10.1017/S0266462300003007
J. R. Hampton, D. Gray, K. W. Clarke, DEFINED DAILY DOSES : INSENSITIVE IN DETERMINING DISEASE PREVALENCE The Pharmaceutical Journal. ,vol. 252, pp. 334- 335 ,(1994)